跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Benzylamine
首页
药物
Benzylamine
Experimental
Small Molecule
Benzylamine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
7
H
9
N
CAS 编号
100-46-9
UNII ID
A1O31ROR09
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Benzylamine analogues
US 7504437 B2
申请人: BTG INT LTD
优先权: 2001
US
8 件公开
Methods of treating alzheimer's disease and pharmaceutical compositions thereof
CN 104619344 A
申请人: LUNDBECK & AMP
优先权: 2013
CN
US
6 件公开
BENZYLAMINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF
EP 4198017 A4
申请人: ACAD OF MILITARY MEDICAL SCIENCES
优先权: 2020
CN
EP
US
WO
5 件公开
Novel benzylamine derivatives as CETP inhibitors
US 2006178514 A1
申请人: BARUAH ANIMA
优先权: 2005
CN
US
4 件公开
[4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-[7-flouro-1-(2-methoxy-ethyl)-4-trifluorom as an inhibitor of mast cell tryptase
US 8217178 B2
申请人: CHOI-SLEDESKI YONG MI
优先权: 2008
CN
US
4 件公开
Polymorphic form of N-[2-(6-fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine hydrochloride for the treatment of Alzheimer's disease
US 10071963 B2
申请人: H LUNDBECK AS
优先权: 2014
CN
US
4 件公开
Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
US 2007015758 A1
申请人: BARUAH ANIMA
优先权: 2006
US
4 件公开
METHOD FOR PRODUCING ALKYLSILYLOXY-SUBSTITUTED BENZYLAMINE COMPOUND
US 20260176238 A1
申请人: SEKISUI MEDICAL CO LTD
优先权: 2022
CN
US
WO
3 件公开
Base-substituted benzylamine analogs for use as coagulation factor xa inhibitors, the production and use thereof
US 2007066539 A1
申请人: STUERZEBECHER JOERG
优先权: 2003
EP
US
3 件公开
4-AMIDINO BENZYLAMINES FOR COSMETIC AND/OR DERMATOLOGICAL USE
US 2011177140 A1
申请人: VOEGELI RAINER
优先权: 2007
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈